Clinicopathologic Characteristics and Prognostic Factors of Stage I and II Endometrial cancer of the uterus: A Study of 59 Cases.
- Author:
Seung Hun SONG
1
;
Jae Kwan LEE
;
Min Jeong OH
;
Jun Young HUR
;
Yong Kyun PARK
;
Ho Suk SAW
Author Information
1. Department of Obstetrics and Gynecology, School of Medicine, Korea University, Seoul, Korea. ktiger@medigate.net
- Publication Type:Original Article
- Keywords:
Uterine endometrial cancer;
Prognostic factor;
DFSR;
5-year survival rate
- MeSH:
Carcinoma, Endometrioid;
Diagnosis;
Disease-Free Survival;
Drug Therapy;
Endometrial Neoplasms*;
Female;
Follow-Up Studies;
Humans;
Medical Records;
Menopause;
Parity;
Retrospective Studies;
Uterine Hemorrhage;
Uterus*
- From:Korean Journal of Obstetrics and Gynecology
2006;49(6):1267-1275
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: The purpose of this study was to evaluate the clinicopathologic findings, treatment, and prognostic factors of uterine endometrial cancer. METHODS: We retrospectively reviewed 59 patients with histologically proven stage I and II endometrial cancer between January 1994 and December 2004, for clinical profiles and survival. The survival of patients was determined by description of last follow up date in medical records or phone calls. RESULTS: The median age at the time of diagnosis was 51 years (range: 30-71 years) and the most common presenting symptom was vaginal bleeding (83.0%). Endometrioid adenocarcinoma was the most common (96.6%) histologic type of all cases. Forty-nine patients (83.0%) were FIGO stage I and 10 patients were stage II (17.0%), and the histological grades of the tumors were 23 (39.0%) grade 1, 17 (28.8%) grade 2, 7 (11.9%) grade 3, and 12 (20.3%) unknown, respectively. All patients were treated by surgery as primary treatment and given postoperative adjuvant therapy including radiation therapy (32.2%), concurrent chemotherapy and radiation therapy (6.8%), and chemotherapy (3.4%). The 5-year disease free survival rate (DFSR) of stage I and stage II were 92.7% and 66.7%, respectively. The age (> or =60) and menopausal status were significant prognostic factors by univariate anlaysis (p=0.0077; p=0.0149, respectively). However, parity, FIGO surgical stage, histological grade, myometrial invasion, and lymph-vascular space invasion were not significant prognostic factors (p>0.05). CONCLUSION: The age (> or =60) and menopause state were significant prognostic factors of stage I and II uterine endometrial cancer affecting survival of the patients.
